Hemorrhagic Fevers, Viral
A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.
Subtype terms (11)
More specific conditions that are subtypes of Hemorrhagic Fevers, Viral in the MeSH hierarchy.
- Dengue
84 drugs (32 approved, 52 experimental)
- Hemorrhagic Fever, American
- Hemorrhagic Fever, Crimean
5 drugs (1 approved, 4 experimental)
- Hemorrhagic Fever, Ebola
55 drugs (17 approved, 38 experimental)
- Hemorrhagic Fever, Omsk
- Hemorrhagic Fever with Renal Syndrome
3 drugs (2 approved, 1 experimental)
- Kyasanur Forest Disease
- Lassa Fever
9 drugs (3 approved, 6 experimental)
- Marburg Virus Disease
13 drugs (2 approved, 11 experimental)
- Rift Valley Fever
6 drugs (2 approved, 4 experimental)
- Yellow Fever
22 drugs (12 approved, 10 experimental)
Drugs by status
Phase 2 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (14)
- Bausch Health Companies
- Novo Nordisk
- GlaxoSmithKline
- Ichor Medical Systems Incorporated
- United States Army
- Mahidol University
- Siriraj Hospital
- Department of Defense
- Guangzhou University
- Landstuhl Regional Medical Center
- Caparra Internal Medicine Research Center
- Ponce School of Medicine
- San Juan Batista Medical School
- EBOVAC2 Consortium
Organization Involved with Phase 1 Indications (23)
- Sarepta Therapeutics
- The EMMES Corporation
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Tubitak
- World Health Organization
- Albert Schweitzer Hospital
- Johns Hopkins University
- University of Hamburg
- University of Maryland
- University of Vermont
- WCCT Global
- New Orleans Center for Clinical Research
- Erciyes University
- Shin Nippon Biomedical Laboratories
- Wellcome Trust
- University of Tuebingen
- MonitorCRO
- German Center for Infection Research
- Leidos
- Clinical Trial Center North
- Philipps University of Marburg
- University of Geneva
Organization Involved with Other Experimental Indications (1)